- Research works
- 46 ▲ 158% vs 2013–17
- Citations
- 2.3k 51.0 per fractional work
- Top-10% rate
- 15.8% record average 16.5%
- Open access
- 57% world 28%
Not ranked overall: Trans Tasman Radiation Oncology Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Physics and Astronomy, 3.6×. Every wedge is a field page.
- Physics and Astronomy 3.6×
- Medicine 3.2×
- Economics, Econometrics and Finance 2.2×
- Health Professions 1.5×
- Mathematics 1.4×
- Biochemistry, Genetics and Molecular Biology 0.7×
- Environmental Science 0.7×
- Social Sciences 0.6×
- Computer Science 0.5×
- Immunology and Microbiology 0.4×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
Which keywords describe research at Trans Tasman Radiation Oncology Group?
By fractional works in all years, weighted toward what it does more of than the world: Radiotherapy, Chemotherapy, Immunotherapy, Monte Carlo Simulation, Dosimetry, Image-Guided Radiotherapy, Radiotherapy Physics and Tumor Microenvironment.
- Resource Planning
- Quality of Life
- Nursing Diagnoses
- Global Warming
- Competition
- Patient Outcomes
- Medical Education
- Health Economics
- Cetuximab
- Survival
- Prognostic Factors
- Cancer Treatment
- Adjuvant Therapy
- PD-1 and PD-L1
- Prostate Cancer
- Climate Change
- Tumor Microenvironment
- Image-Guided Radiotherapy
- Dosimetry
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Monte Carlo Simulation
- Radiotherapy Physics
- Tumor Staging
- Epidemiology
- Immune Checkpoint Blockade
- Clinical Trials
- Biomarkers
- Clinical Guidelines
- Quality Improvement
- CT Screening
- Genetic Mutations
- Lung Cancer
- Melanoma
- Squamous Cell Carcinoma
- Global Access
- Greenhouse Gas Emissions
- Nursing Documentation
- Railway Deregulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Radiotherapy4▲ 24×9 topics
- Chemotherapy3▲ 10×16 topics
- Immunotherapy3▲ 11×11 topics
- Dosimetry2▲ 56×2 topics
- Monte Carlo Simulation2▲ 17×2 topics
- Image-Guided Radiotherapy2▲ 95×1 topic
- Radiotherapy Physics2▲ 95×1 topic
- Tumor Microenvironment2▲ 13×5 topics
- Tumor Staging2▲ 41×2 topics
- Climate Change2▲ 1.28×6 topics
- Epidemiology2▼ 0.84×8 topics
- Prostate Cancer2▲ 22×2 topics
- Immune Checkpoint Blockade1▲ 57×1 topic
- PD-1 and PD-L11▲ 57×1 topic
- Clinical Trials1▲ 4.7×7 topics
- Adjuvant Therapy1▲ 23×2 topics
- Biomarkers1▲ 4.4×5 topics
- Cancer Treatment1▲ 9.9×3 topics
- Clinical Guidelines1▲ 8.2×2 topics
- Prognostic Factors1▲ 5.7×9 topics
- Quality Improvement1▲ 12×2 topics
- Survival1▲ 20×3 topics
- CT Screening1▲ 43×1 topic
- Cetuximab1▲ 30×2 topics
- Genetic Mutations1▲ 4.5×5 topics
- Health Economics1▲ 41×2 topics
- Lung Cancer1▲ 14×1 topic
- Medical Education1▲ 10×3 topics
- Melanoma1▲ 46×2 topics
- Patient Outcomes1▲ 37×2 topics
- Squamous Cell Carcinoma1▲ 27×2 topics
- Competition1▲ 26×1 topic
- Global Access1▲ 40×1 topic
- Global Warming1▲ 6.2×3 topics
- Greenhouse Gas Emissions1▲ 11×2 topics
- Nursing Diagnoses1▲ 156×1 topic
- Nursing Documentation1▲ 156×1 topic
- Quality of Life1▲ 1.64×5 topics
- Railway Deregulation1▲ 224×1 topic
- Resource Planning1▲ 107×1 topic
Which research topics does Trans Tasman Radiation Oncology Group publish most on?
By volume in 2022–2025: Advanced Radiotherapy Techniques, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment and Cancer survivorship and care.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Radiotherapy Techniques Radiation 1 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 4 Cancer survivorship and care Oncology 0 works
- 5 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 0 works
- 6 Public Health and Nutrition Pediatrics, Perinatology and Child Health 0 works
- 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
- 8 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 9 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 10 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Trans Tasman Radiation Oncology Group's research output changed?
Output in 2018–2022 was 158% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Newcastle
- University of Newcastle Australia
- John Hunter Hospital
- Hunter Medical Research Institute
- Hunter New England Local Health District
- Hunter Water
- ARC Centre of Excellence for Enabling Eco-Efficient Beneficiation of Minerals
- John Hunter Children's Hospital
- CRC CARE
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.